Risk factor
Very poor trading liquidity
Profitability factor
Undervalued vs peers
About
CVC Technologies Inc. is a global supplier specializing in the production and distribution of a comprehensive array of pharmaceutical packaging machinery. Their extensive product portfolio addresses diverse packaging needs, featuring advanced tablet counting systems such as bottle unscramblers, air rinsers, tablet and capsule counters/fillers, desiccant and cotton/foam inserters, and a variety of cappers (including chuck, rotary, vial, in-line, and vibratory press models). Other offerings in this category include induction cap sealers, shrink bundlers and tunnels, intermittent cartoners, and sophisticated track and trace machines. The company also provides a wide selection of labeling equipment, like top/bottom/side, wrap-around, and front/back labelers, alongside leaflet topserters, shrink sleeve applicators, and specialized labeler inspection systems. For liquid and powder applications, CVC offers integrated solutions, encompassing bottle unscramblers and air rinsers, liquid fillers and cappers, dedicated capping machines, induction capsealers, labeling units, and cartoner/shrink systems. Further product offerings extend to encapsulation machines, aluminum foil sealing devices, and semi-automatic tablet/capsule counters. Auxiliary equipment is also available, comprising items like jet masters, capsule printing machines, paste making systems, gelatin melting tanks, medicine preparation and drying systems, gelatin reclaim systems, and capsule inspection machines. Beyond its machinery, CVC Technologies Inc. delivers a full suite of support services. These include expert packaging line design, factory acceptance testing, technical phone assistance, field service and preventative maintenance, as well as installation, startup, and training programs. Established in 1979, the company is based in Taichung, Taiwan.
Company Valuation
From both historical and forecast perspectives, the stock is underpriced compared to similar stocks. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITDA,
Target Price
The average target price of 4744.TWO is 40.0 and suggests 25.4% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to